Table 2.

Discriminant analysis of the six candidate miRNAs as predictive markers of recurrence in patients with BTC.

Discriminant	Accuracy (%)	Sensitivity (%)	Specificity (%)	AUC
miR-1225-3p	81.8	76.9	88.9	0.744
miR-1234-3p	72.7	69.2	77.8	0.641
miR-1260b	72.7	53.8	100.0	0.803
miR-1470	72.7	69.2	77.8	0.675
miR-6834-3p	77.2	76.9	77.8	0.821
miR-6875-5p	81.8	76.9	88.9	0.778

Abbreviations: BTC, bile tract cancer; AUC, area under the curve.